What does Apotheek Schockaert M. do?

Apotheek Schockaert M. is a pharmacy in Dendermonde. Private Limited, started on 25 March 2010, 1 establishment.

What is the address of Apotheek Schockaert M.?

The registered office of Apotheek Schockaert M. is located at Burgemeester Potiaulaan (STG) 3, 9200 Dendermonde.

Is Apotheek Schockaert M. still active?

Yes. According to the CBE (30 September 2026) Apotheek Schockaert M. is active, legal situation “Normale toestand”, started on 25 March 2010.

Is Apotheek Schockaert M. registered on Peppol?

Yes, Apotheek Schockaert M. is registered on the Peppol network with ID 0208:0824313126.

What is the enterprise number of Apotheek Schockaert M.?

The enterprise number of Apotheek Schockaert M. is BE0824313126.

When was Apotheek Schockaert M. founded?

Apotheek Schockaert M. was founded on 25 March 2010.

Who are the directors of Apotheek Schockaert M.?

According to the 2025 annual accounts, the directors of Apotheek Schockaert M. are: IMMO SCHOCK BV.

Is Apotheek Schockaert M. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 March 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Schockaert M. make in 2025?

Apotheek Schockaert M. posted a profit after taxes of € 19,059 in financial year 2025.

What is the revenue of Apotheek Schockaert M.?

As a small company, Apotheek Schockaert M. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 47,103.

Apotheek Schockaert M. (Private Limited) - Dendermonde

Dossier Apotheek Schockaert M., printed on 30 September 2026 from databakkes.be/en/0824313126/apotheek-schockaert-m. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 57 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Apotheek Schockaert M. from Dendermonde, company number BE0824313126, closed financial year 2025 with a result of € 19,059 after tax. For that financial year Apotheek Schockaert M. recorded a gross margin of € 47,103 and equity of € 119,990. Compared with financial year 2024, the result moved from € 15,093 to € 19,059. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Growing

€ 119,990

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 19,059

▲ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 80,892

▼ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 19,990.

People and assets in 2025

Vehicles and equipment

€ 782

▼ 73% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 100,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 72,036

▲ 63% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18

▼ 98% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 27,936 Gross margin 2022: € 27,936 First fiscal year in the series	€ 51,610 Gross margin 2023: € 51,610 ▲ 85% vs 2022 (€ 27,936) Favourable step	€ 44,905 Gross margin 2024: € 44,905 ▼ 13% vs 2023 (€ 51,610) Unfavourable step	€ 47,103 Gross margin 2025: € 47,103 ▲ 5% vs 2024 (€ 44,905) Favourable step	▲ 5%
Profit after taxes	€ -2,216 Profit after taxes 2022: € -2,216 First fiscal year in the series	€ 22,872 Profit after taxes 2023: € 22,872 ▲ € 25,088 vs 2022 (€ -2,216) Favourable step	€ 15,093 Profit after taxes 2024: € 15,093 ▼ 34% vs 2023 (€ 22,872) Unfavourable step	€ 19,059 Profit after taxes 2025: € 19,059 ▲ 26% vs 2024 (€ 15,093) Favourable step	▲ 26%
Equity	€ 62,967 Equity 2022: € 62,967 First fiscal year in the series	€ 85,839 Equity 2023: € 85,839 ▲ 36% vs 2022 (€ 62,967) Favourable step	€ 100,931 Equity 2024: € 100,931 ▲ 18% vs 2023 (€ 85,839) Favourable step	€ 119,990 Equity 2025: € 119,990 ▲ 19% vs 2024 (€ 100,931) Favourable step	▲ 19%
Total debts	€ 300,620 Total debts 2022: € 300,620 First fiscal year in the series	€ 308,960 Total debts 2023: € 308,960 ▲ 3% vs 2022 (€ 300,620) Unfavourable step	€ 312,952 Total debts 2024: € 312,952 ▲ 1% vs 2023 (€ 308,960) Unfavourable step	€ 353,185 Total debts 2025: € 353,185 ▲ 13% vs 2024 (€ 312,952) Unfavourable step	▲ 13%
Cash	€ 117,021 Cash 2022: € 117,021 First fiscal year in the series	€ 139,126 Cash 2023: € 139,126 ▲ 19% vs 2022 (€ 117,021) Favourable step	€ 88,093 Cash 2024: € 88,093 ▼ 37% vs 2023 (€ 139,126) Unfavourable step	€ 80,892 Cash 2025: € 80,892 ▼ 8% vs 2024 (€ 88,093) Unfavourable step	▼ 8%
Retained profit	€ -37,033 Retained profit 2022: € -37,033 First fiscal year in the series	€ -14,161 Retained profit 2023: € -14,161 ▲ € 22,872 vs 2022 (€ -37,033) Favourable step	€ 931 Retained profit 2024: € 931 ▲ € 15,093 vs 2023 (€ -14,161) Favourable step	€ 19,990 Retained profit 2025: € 19,990 ▲ € 19,059 vs 2024 (€ 931) Favourable step	▲ € 19,059
Bank debt	€ 100,000 Bank debt 2022: € 100,000 First fiscal year in the series	€ 100,000 Bank debt 2023: € 100,000 Unchanged (€ 100,000) Unchanged	€ 100,000 Bank debt 2024: € 100,000 Unchanged (€ 100,000) Unchanged	€ 100,000 Bank debt 2025: € 100,000 Unchanged (€ 100,000) Unchanged
Balance sheet total	€ 363,587 Balance sheet total 2022: € 363,587 First fiscal year in the series	€ 394,799 Balance sheet total 2023: € 394,799 ▲ 9% vs 2022 (€ 363,587) Unchanged	€ 413,883 Balance sheet total 2024: € 413,883 ▲ 5% vs 2023 (€ 394,799) Unchanged	€ 473,175 Balance sheet total 2025: € 473,175 ▲ 14% vs 2024 (€ 413,883) Unchanged	▲ 14%

Key figures of Apotheek Schockaert M., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Schockaert M.?

What happened at Apotheek Schockaert M. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 19,059 (▲ 26% vs 2024). Source: NBB ↗
Apr 1, 2010 New establishment in Dendermonde. KBO
Mar 25, 2010 Start of the company according to the CBE. KBO
2010 IMMO SCHOCK BV became a director. NBB

In short

From € 2,216 loss in 2022 to € 19,059 profit in 2025.

Best year ever: 2023, with € 22,872 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Apotheek Schockaert M.? We notify you, reason included.

Follow Apotheek Schockaert M.

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit